Anil Singhvi bullish on 1 largecap and 2 midcap stocks: Check stop losses and targets

ZeeBiz WebTeam | Jun 17, 2025, 08:57 AM IST

:Indian equities in the previous session ended higher shrugging off the weak global sentiment. At the close, Nifty settled close to 25,000 levels with all the sectors ending in the green. So, as the FIIs and even the broader macros, continued to support Indian equities- Zee Business Managing Editor has recommended buying the below scrip. 
 

1/10

Biocon

Biocon

The expert has recommended buying the futures of this stock. Buy Biocon Futures:

 

whatapp
2/10

QIP launched

QIP launched

Biocon launched Qualified Institutional Placement (QIP) for raising Rs 4,500 crore.  As part of the offering, the company will issue up to 139 million new shares — 11.6 per cent of its outstanding equity shares.

whatapp
3/10

Buy Biocon| Target: Rs 362, 366, 371

Buy Biocon| Target: Rs 362, 366, 371

The stop loss suggested for the trade is Rs 352.

whatapp
4/10

Schneider Electric

Schneider Electric

Market expert has recommended buying this midcap heavy electrical equipment company shares.

whatapp
5/10

Goldman Sachs upbeat

Goldman Sachs upbeat

Goldman Sachs upgraded the stock to 'buy' from the earlier 'sell' call. Target Price raised to 910 from 505 

whatapp
6/10

Buy Schneider Electric| Target: Rs 758, 765, 775

Buy Schneider Electric| Target: Rs 758, 765, 775

The stop loss for the trade is Rs 735 per share.

whatapp
7/10

Tanla Platforms

Tanla Platforms

The market guru has adviced buying this scrip.

whatapp
8/10

Tanla Platforms buyback

Tanla Platforms buyback

The company's board on Monday approved Rs 175 crore share buyback at `Rs 875/share. The buyback price implies 33 per cent gains from the previous close.

whatapp
9/10

Buy Tanla Platforms| Tareget Rs 670, 678, 690

Buy Tanla Platforms| Tareget Rs 670, 678, 690

The stop loss recommended for the trade is Rs 649 

whatapp
10/10

Disclaimer

Disclaimer

The expert has recommended buying the scrips. Investors should do their own analysis basis their risk profile and then only take a dip into them.

whatapp

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x